1
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E. (hudson.polonini@fagron.com)
Int J Pharm Compound - 2020 - ;24,3:252-262
3
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide,
Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. ( hudson@ortofarma.com.br)
Int J Pharm Compound - 2018 - ;22,6:516-526
4
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A. (anderson@ortofarma.com.br)
Int J Pharm Compound - 2017 - ; 3: 255-263
5
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A. (anderson@ortofarma.com.br)
Int J Pharm Compound - 2017 - ; 21:4 :339-346
6
Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions.
Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO. (anderson@ortofarma.com.br)
Pharmazie - 2016 - 71: 185?191.
7
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F. ()
Int J Pharm Compound - 2016 - ; 20, 2: 167-174.
8
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O. ()
Int J Pharm Compound - 2016 - ; 20, 5 : 426-434.
9
Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O. (anderson@ortofarma.com.br)
EJHP - 2016 - ; 23: 352-358.
10
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B. (nadiacritt@gmail.com)
J Pharm Biomed Anal - 2015 - ; 118: 105-112.
|
